LIS Technologies

We are an early-stage uranium enrichment company focused on the development of patented and other proprietary laser-based uranium enrichment technologies and related capabilities for the production of enriched uranium to service the growing needs of the U.S. domestic and international nuclear energy industry. Our proprietary technology encompasses the Condensation Repression Isotope-Selective Laser Activation (“CRISLA”) process, and other proprietary processes and systems (which we refer to as the “LIST technology”). Our target markets include operators of commercial light-water reactors (“LWRs”) as well as developers and operators of advanced nuclear reactor technologies, including small modular reactors (“SMRs”) and microreactors (“MMRs”). Subject to obtaining the necessary regulatory approvals and developing commercial-scale operations, we intend to produce and supply enriched uranium to participants in our target markets.